Ambu

Britt Meelby Jensen promised 10–13%; 12–14%. Now it is 13.1%; 13.0%.

🇩🇰 Denmark · Medical devices

Ambu100IntegrityBJBritt Meelby JensenCEO, 2022–, AmbuPromisedhow much sales grew in 2024/2510–13%; 12–14%4 November 2024

🇩🇰 Denmark · Medical devices

Ambu105IntegrityBJBritt Meelby JensenCEO, 2022–, Ambu

Did Ambu keep its promise to grow 10–13% in 2024/25? (plain)

The new promiseThe endoscope maker hit the top of its growth range and the middle of its margin range.

Max Noble Odds: 50% chance she keeps it. They move with every call. Against the odds you win more, and lose more.

She promised

Sales would grow 10–13% with a 12–14% margin.

Britt Meelby Jensen, CEO, 2022–, on 4 November 2024.

She got

Stamp: Kept.

Why, says the company

Better gross margin and costs growing slower than sales.

How bad

Nothing: the promise was met. Score 100 → 105.

In the company’s own words

Not needed: target met. Ambu credited an improved gross margin and operating leverage.

The sources